Active Shortage

APO-RISPERIDONE

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-RISPERIDONE in Canada?

Yes. APO-RISPERIDONE 0.50MG has an active shortage reported to Health Canada (last updated August 6, 2026).

Why is APO-RISPERIDONE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-RISPERIDONE be available again?

The estimated resolution date (August 7, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products

Affected strength0.50MG

Last updated2026-08-06

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

RISPERDAL ORAL SOLUTION

JANSSEN INC

1MG · DIN 02236950

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

PMS-RISPERIDONE

PHARMASCIENCE INC

0.25MG · DIN 02252007

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

ACT RISPERIDONE

ACTAVIS PHARMA COMPANY

0.25MG · DIN 02282585

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

APO-RISPERIDONE

APOTEX INC

2.0MG · DIN 02282143

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

RISPERDAL M-TAB

JANSSEN INC

1MG · DIN 02247705

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

RATIO-RISPERIDONE

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED

0.25MG · DIN 02264757

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02282127

Strength

0.50MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

RISPERIDONE

See all RISPERIDONE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-08-06

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244